Urgent FDA Alert: Vitruvias Therapeutics Thyroid Tablets Upgraded to Class I Recall Due to Severe Health Risks
Urgent FDA Alert: Vitruvias Therapeutics Thyroid Tablets Upgraded to Class I Recall Due to Severe Health Risks
FDA Recall
Urgent FDA Alert: Vitruvias Therapeutics Thyroid Tablets Upgraded to Class I Recall Due to Severe Health Risks